We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Synpromics Raises £5.2m of New Investment

News   Apr 20, 2017 | Original story from Synpromics

 
Synpromics Raises £5.2m of New Investment
 
 
 

RELATED ARTICLES

Bioactive Agents Improve Synthetic Bone Substitutes

News

Synthetic bone substitutes are promising materials for bone defect repair, but their efficacy can be substantially improved by bioactive agents such as growth factors. In a new study, researchers have modified beta-tricalcium phosphate (β-TCP) with increasing quantities of bone morphogenetic protein 2 (BMP-2) derived from E. coli and shown improved bone healing.

READ MORE

How Does DEET Keep Mosquitoes at Bay?

News

Since its invention during WWII, researchers have been trying to pinpoint precisely how DEET actually affects mosquitos. New research suggests DEET may chemically “cloak” humans from malaria-carrying mosquitos, rather than repel them.

READ MORE

Plant-based Compound Helps Overcome Gene Therapy Challenges

News

Researchers believe they have found a way to sidestep some of the current difficulties associated with gene therapy, resulting in a better method that would save money and improve treatment outcomes.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE